top of page

 

Tirzepatide

Dual GIP and GLP-1 receptor agonist for diabetes and weight management

⭐⭐⭐⭐⭐Clinically Proven Results

Exceptional Weight Loss

Clinical programs consistently show 15–22% average weight reduction, leading the category.

Heart Health Benefits

Improves cardiometabolic markers while maintaining effective glycemic control.

FDA Approved*

Breakthrough therapy approved for diabetes and widely used in weight-management protocols.

  •  

  •  

Trizapatide

SKU: 364215375135191
$200.00Price
Quantity
bottom of page